Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 74
Selected: 0
NCT IDTitle
NCT04200573Effect of Hepatic Impairment on the Pharmacokinetics of a Single Dose of TD-9855
NCT01702194TD-1211 IV/Oral Mass Balance Study
NCT03750565Multiple Dose Ethnobridging PK Study in Healthy Subjects
NCT04589260TD-1058 First-In-Human Study in Healthy Subjects and Subjects With Idiopathic Pulmonary Fibrosis
NCT04402866TD-0903 for ALI Associated With COVID-19
NCT00391820Evaluate the Safety and Efficacy of a 5-HT4 Agonist in Chronic Constipation (ACCORD Trial)
NCT02459080Efficacy Study of Nebulized TD-4208 for Chronic Obstructive Pulmonary Disease (COPD)
NCT01693692Phase 2 Study of TD-9855 to Treat Fibromyalgia
NCT02663089A Phase 1 (Ph1), Single Dose (SD), GSK961081 Absorption, Distribution, Metabolism, and Excretion (ADME) Study in Healthy Subjects
NCT02040792A 28-Day Parallel Group Study of TD-4208 in Chronic Obstructive Pulmonary Disease (COPD)
NCT02581592Pharmacokinetics of TD-4208 in Patients With Moderate Hepatic Impairment
NCT01467726Safety, Pharmacokinetics and Pharmacodynamics of Velusetrag in Healthy Elderly Subjects
NCT00550225Succinate Salt Version of GSK961081 for Healthy Volunteers
NCT02267525The Diabetic and Idiopathic Gastroparesis Efficacy, Safety, and Tolerability (DIGEST) Study
NCT01459926A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Efficacy of TD-1211 in Subjects With Opioid-Induced Constipation
NCT03829657Phase 3 Clinical Effect Durability of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure
NCT02578082Pharmacokinetics of TD-4208 in Patients With Severe Renal Impairment
NCT01458340A Study of TD-9855 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
NCT01644240A Phase 1, Multiple Intravenous Dose Study to Examine Safety, Tolerability, and PK of Intravenous TD-8954, a 5-HT4 Receptor Agonist, in Healthy Subjects
NCT01333540A Study to Assess the Safety, Tolerability and Clinical Activity of TD-1211 in Patients With Opioid-Induced Constipation
NCT02109172A 7-Day Cross-over Study of QD (Once Daily) and BID (Twice Daily) TD-4208 in Chronic Obstructive Pulmonary Disease (COPD)
NCT017044047 Days of TD-4208 in Subjects With Chronic Obstructive Pulmonary Disease
NCT04315558Revefenacin in Acute Respiratory Insufficiency in COPD
NCT02954263Multiple Ascending Dose Study of TD-1439 in Healthy Adult and Elderly Subjects
NCT02818686TD-1473 for Active Ulcerative Colitis (UC)
NCT02657122SAD and MAD Study to Evaluate Safety, Tolerability, and Pharmacokinetics (PK) of TD-1473 in Healthy Subjects
NCT02518139A 52-Week Parallel Group Safety Study of TD-4208 in Chronic Obstructive Pulmonary Disease (COPD)
NCT03635112Efficacy and Safety of TD-1473 in Crohn's Disease
NCT03103412TD-3504 SAD in Healthy Subjects and Subjects With Ulcerative Colitis (UC)
NCT02903095Single Ascending Dose Study of TD-1439 in Healthy Subjects
NCT01718938Phase 2 Study of Velusetrag in Diabetic or Idiopathic Gastroparesis
NCT03652038Single and Multiple Ascending Dose Study of TD-8236 by Inhalation
NCT04044339Single and Multiple Ascending Dose, First-in- Human Study in Healthy Subjects
NCT03573817A 42-day Parallel Group Safety Study of Revefenacin and Formoterol, Administered in Sequence and as a Combination, in Participants With COPD
NCT05696717Phase 3 Efficacy and Durability of Ampreloxetine for the Treatment of Symptomatic NOH in Participants with Multiple System Atrophy
NCT04150341Effect of Inhaled TD-8236 on Allergen-induced Asthmatic Response
NCT00674817An Investigation Of The Interaction Of GSK961081 With Inhaled Beta-Agonist And Anti-Muscarinic Drugs.
NCT03555617Food-effect, Drug-Drug Interaction (DDI), and Formulation Bridging Study
NCT02753855Pharmacokinetics of Telavancin in Normal and Obese Subjects
NCT02512510Efficacy Study of Nebulized TD-4208 for Chronic Obstructive Pulmonary Disease (COPD)
NCT01953081A Randomized, Double-Blind Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of a Single Dose of Intravenous TD-8954 Compared With Metoclopramide in Critically Ill Patients With Enteral Feeding Intolerance
NCT02705755TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH)
NCT02392208Effect of Dialysis on the Pharmacokinetics of Telavancin in Patients With Chronic Kidney Disease Stage 5
NCT04587713Single Dose Bioavailability and Ethnobridging PK Study in Healthy Subjects
NCT05091723TD-0903 Pharmacokinetics Study in Healthy Participants With Supplemental Oxygenation
NCT04350736First in Human SAD and MAD Study of Inhaled TD-0903, a Potential Treatment for ALI Associated With COVID-19
NCT01791049TD-1607 SAD Study in Healthy Subjects
NCT01924143TD-9855 Mass Balance Study
NCT02116543TD-6450 MAD Study in HCV Infected Subjects
NCT01321879Study to Evaluate the Safety and Efficacy of Telavancin in the Treatment of Gram Positive Bloodstream Infections in Cancer Patients